Keep Us Strong WikiLeaks logo

Currently released so far... 251287 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AEMR ASEC AMGT AE AS AMED AVIAN AU AF AORC AGENDA AO AR AM APER AFIN ATRN AJ ABUD ARABL AL AG AODE ALOW ADANA AADP AND APECO ACABQ ASEAN AA AFFAIRS AID AGR AY AGS AFSI AGOA AMB ARF ANET ASCH ACOA AFLU AFSN AMEX AFDB ABLD AESC AFGHANISTAN AINF AVIATION ARR ARSO ANDREW ASSEMBLY AIDS APRC ASSK ADCO ASIG AC AZ APEC AFINM ADB AP ACOTA ASEX ACKM ASUP ANTITERRORISM ADPM AINR ARABLEAGUE AGAO AORG AMTC AIN ACCOUNT ASECAFINGMGRIZOREPTU AIDAC AINT ARCH AMGTKSUP ALAMI AMCHAMS ALJAZEERA AVIANFLU AORD AOREC ALIREZA AOMS AMGMT ABDALLAH AORCAE AHMED ACCELERATED AUC ALZUGUREN ANGEL AORL ASECIR AMG AMBASSADOR AEMRASECCASCKFLOMARRPRELPINRAMGTJMXL ADM ASES ABMC AER AMER ASE AMGTHA ARNOLDFREDERICK AOPC ACS AFL AEGR ASED AFPREL AGRI AMCHAM ARNOLD AN ANATO AME APERTH ASECSI AT ACDA ASEDC AIT AMERICA AMLB AMGE ACTION AGMT AFINIZ ASECVE ADRC ABER AGIT APCS AEMED ARABBL ARC ASO AIAG ACEC ASR ASECM ARG AEC ABT ADIP ADCP ANARCHISTS AORCUN AOWC ASJA AALC AX AROC ARM AGENCIES ALBE AK AZE AOPR AREP AMIA ASCE ALANAZI ABDULRAHMEN ABDULHADI AINFCY ARMS ASECEFINKCRMKPAOPTERKHLSAEMRNS AGRICULTURE AFPK AOCR ALEXANDER ATRD ATFN ABLG AORCD AFGHAN ARAS AORCYM AVERY ALVAREZ ACBAQ ALOWAR ANTOINE ABLDG ALAB AMERICAS AFAF ASECAFIN ASEK ASCC AMCT AMGTATK AMT APDC AEMRS ASECE AFSA ATRA ARTICLE ARENA AISG AEMRBC AFR AEIR ASECAF AFARI AMPR ASPA ASOC ANTONIO AORCL ASECARP APRM AUSTRALIAGROUP ASEG AFOR AEAID AMEDI ASECTH ASIC AFDIN AGUIRRE AUNR ASFC AOIC ANTXON ASA ASECCASC ALI AORCEUNPREFPRELSMIGBN ASECKHLS ASSSEMBLY ASECVZ AI ASECPGOV ASIR ASCEC ASAC ARAB AIEA ADMIRAL AUSGR AQ AMTG ARRMZY ANC APR AMAT AIHRC AFU ADEL AECL ACAO AMEMR ADEP AV AW AOR ALL ALOUNI AORCUNGA ALNEA ASC AORCO ARMITAGE AGENGA AGRIC AEM ACOAAMGT AGUILAR AFPHUM AMEDCASCKFLO AFZAL AAA ATPDEA ASECPHUM ASECKFRDCVISKIRFPHUMSMIGEG
ETRD ETTC EU ECON EFIN EAGR EAID ELAB EINV ENIV ENRG EPET EZ ELTN ELECTIONS ECPS ET ER EG EUN EIND ECONOMICS EMIN ECIN EINT EWWT EAIR EN ENGR ES EI ETMIN EL EPA EARG EFIS ECONOMY EC EK ELAM ECONOMIC EAR ESDP ECCP ELN EUM EUMEM ECA EAP ELEC ECOWAS EFTA EXIM ETTD EDRC ECOSOC ECPSN ENVIRONMENT ECO EMAIL ECTRD EREL EDU ENERG ENERGY ENVR ETRAD EAC EXTERNAL EFIC ECIP ERTD EUC ENRGMO EINZ ESTH ECCT EAGER ECPN ELNT ERD EGEN ETRN EIVN ETDR EXEC EIAD EIAR EVN EPRT ETTF ENGY EAIDCIN EXPORT ETRC ESA EIB EAPC EPIT ESOCI ETRB EINDQTRD ENRC EGOV ECLAC EUR ELF ETEL ENRGUA EVIN EARI ESCAP EID ERIN ELAN ENVT EDEV EWWY EXBS ECOM EV ELNTECON ECE ETRDGK EPETEIND ESCI ETRDAORC EAIDETRD ETTR EMS EAGRECONEINVPGOVBN EBRD EUREM ERGR EAGRBN EAUD EFI ETRDEINVECINPGOVCS EPEC ETRO ENRGY EGAR ESSO EGAD ENV ENER EAIDXMXAXBXFFR ELA EET EINVETRD EETC EIDN ERGY ETRDPGOV EING EMINCG EINVECON EURM EEC EICN EINO EPSC ELAP ELABPGOVBN EE ESPS ETRA ECONETRDBESPAR ERICKSON EEOC EVENTS EPIN EB ECUN EPWR ENG EX EH EAIDAR EAIS ELBA EPETUN ETRDEIQ EENV ECPC ETRP ECONENRG EUEAID EWT EEB EAIDNI ESENV EADM ECN ENRGKNNP ETAD ETR ECONETRDEAGRJA ETRG ETER EDUC EITC EBUD EAIF EBEXP EAIDS EITI EGOVSY EFQ ECOQKPKO ETRGY ESF EUE EAIC EPGOV ENFR EAGRE ENRD EINTECPS EAVI ETC ETCC EIAID EAIDAF EAGREAIDPGOVPRELBN EAOD ETRDA EURN EASS EINVA EAIDRW EON ECOR EPREL EGPHUM ELTM ECOS EINN ENNP EUPGOV EAGRTR ECONCS ETIO ETRDGR EAIDB EISNAR EIFN ESPINOSA EAIDASEC ELIN EWTR EMED ETFN ETT EADI EPTER ELDIN EINVEFIN ESS ENRGIZ EQRD ESOC ETRDECD ECINECONCS EAIT ECONEAIR ECONEFIN EUNJ ENRGKNNPMNUCPARMPRELNPTIAEAJMXL ELAD EFIM ETIC EFND EFN ETLN ENGRD EWRG ETA EIN EAIRECONRP EXIMOPIC ERA ENRGJM ECONEGE ENVI ECHEVARRIA EMINETRD EAD ECONIZ EENG ELBR EWWC ELTD EAIDMG ETRK EIPR EISNLN ETEX EPTED EFINECONCS EPCS EAG ETRDKIPR ED EAIO ETRDEC ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID ECONEINVEFINPGOVIZ ERNG EFINU EURFOR EWWI ELTNSNAR ETD EAIRASECCASCID EOXC ESTN EAIDAORC EAGRRP ETRDEMIN ELABPHUMSMIGKCRMBN ETRDEINVTINTCS EGHG EAIDPHUMPRELUG EAGRBTIOBEXPETRDBN EDA EPETPGOV ELAINE EUCOM EMW EFINECONEAIDUNGAGM ELB EINDETRD EMI ETRDECONWTOCS EINR ESTRADA EHUM EFNI ELABV ENR EMN EXO EWWTPRELPGOVMASSMARRBN EATO END EP EINVETC ECONEFINETRDPGOVEAGRPTERKTFNKCRMEAID ELTRN EIQ ETTW EAI ENGRG ETRED ENDURING ETTRD EAIDEGZ EOCN EINF EUPREL ENRL ECPO ENLT EEFIN EPPD ECOIN EUEAGR EISL EIDE ENRGSD EINVECONSENVCSJA EAIG ENTG EEPET EUNCH EPECO ETZ EPAT EPTE EAIRGM ETRDPREL EUNGRSISAFPKSYLESO ETTN EINVKSCA ESLCO EBMGT ENRGTRGYETRDBEXPBTIOSZ EFLU ELND EFINOECD EAIDHO EDUARDO ENEG ECONEINVETRDEFINELABETRDKTDBPGOVOPIC EFINTS ECONQH ENRGPREL EUNPHUM EINDIR EPE EMINECINECONSENVTBIONS EFINM ECRM EQ EWWTSP ECONPGOVBN
KFLO KPKO KDEM KFLU KTEX KMDR KPAO KCRM KIDE KN KNNP KG KMCA KZ KJUS KWBG KU KDMR KAWC KCOR KPAL KOMC KTDB KTIA KISL KHIV KHUM KTER KCFE KTFN KS KIRF KTIP KIRC KSCA KICA KIPR KPWR KWMN KE KGIC KGIT KSTC KACT KSEP KFRD KUNR KHLS KCRS KRVC KUWAIT KVPR KSRE KMPI KMRS KNRV KNEI KCIP KSEO KITA KDRG KV KSUM KCUL KPET KBCT KO KSEC KOLY KNAR KGHG KSAF KWNM KNUC KMNP KVIR KPOL KOCI KPIR KLIG KSAC KSTH KNPT KINL KPRP KRIM KICC KIFR KPRV KAWK KFIN KT KVRC KR KHDP KGOV KPOW KTBT KPMI KPOA KRIF KEDEM KFSC KY KGCC KATRINA KWAC KSPR KTBD KBIO KSCI KRCM KNNB KBNC KIMT KCSY KINR KRAD KMFO KCORR KW KDEMSOCI KNEP KFPC KEMPI KBTR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KNPP KTTB KTFIN KBTS KCOM KFTN KMOC KOR KDP KPOP KGHA KSLG KMCR KJUST KUM KMSG KHPD KREC KIPRTRD KPREL KEN KCSA KCRIM KGLB KAKA KWWT KUNP KCRN KISLPINR KLFU KUNC KEDU KCMA KREF KPAS KRKO KNNC KLHS KWAK KOC KAPO KTDD KOGL KLAP KECF KCRCM KNDP KSEAO KCIS KISM KREL KISR KISC KKPO KWCR KPFO KUS KX KWCI KRFD KWPG KTRD KH KLSO KEVIN KEANE KACW KWRF KNAO KETTC KTAO KWIR KVCORR KDEMGT KPLS KICT KWGB KIDS KSCS KIRP KSTCPL KDEN KLAB KFLOA KIND KMIG KPPAO KPRO KLEG KGKG KCUM KTTP KWPA KIIP KPEO KICR KNNA KMGT KCROM KMCC KLPM KNNPGM KSIA KSI KWWW KOMS KESS KMCAJO KWN KTDM KDCM KCM KVPRKHLS KENV KCCP KGCN KCEM KEMR KWMNKDEM KNNPPARM KDRM KWIM KJRE KAID KWMM KPAONZ KUAE KTFR KIF KNAP KPSC KSOCI KCWI KAUST KPIN KCHG KLBO KIRCOEXC KI KIRCHOFF KSTT KNPR KDRL KCFC KLTN KPAOKMDRKE KPALAOIS KESO KKOR KSMT KFTFN KTFM KDEMK KPKP KOCM KNN KISLSCUL KFRDSOCIRO KINT KRG KWMNSMIG KSTCC KPAOY KFOR KWPR KSEPCVIS KGIV KSEI KIL KWMNPHUMPRELKPAOZW KQ KEMS KHSL KTNF KPDD KANSOU KKIV KFCE KTTC KGH KNNNP KK KSCT KWNN KAWX KOMCSG KEIM KTSD KFIU KDTB KFGM KACP KWWMN KWAWC KSPA KGICKS KNUP KNNO KISLAO KTPN KSTS KPRM KPALPREL KPO KTLA KCRP KNMP KAWCK KCERS KDUM KEDM KTIALG KWUN KPTS KPEM KMEPI KAWL KHMN KCRO KCMR KPTD KCROR KMPT KTRF KSKN KMAC KUK KIRL KEM KSOC KBTC KOM KINP KDEMAF KTNBT KISK KRM KWBW KBWG KNNPMNUC KNOP KSUP KCOG KNET KWBC KESP KMRD KEBG KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KPWG KOMCCO KRGY KNNF KPROG KJAN KFRED KPOKO KM KWMNCS KMPF KJWC KJU KSMIG KALR KRAL KDGOV KPA KCRMJA KCRI KAYLA KPGOV KRD KNNPCH KFEM KPRD KFAM KALM KIPRETRDKCRM KMPP KADM KRFR KMWN KWRG KTIAPARM KTIAEUN KRDP KLIP KDDEM KTIAIC KWKN KPAD KDM KRCS KWBGSY KEAI KIVP KPAOPREL KUNH KTSC KIPT KNP KJUSTH KGOR KEPREL KHSA KGHGHIV KNNR KOMH KRCIM KWPB KWIC KINF KPER KILS KA KNRG KCSI KFRP KLFLO KFE KNPPIS KQM KQRDQ KERG KPAOPHUM KSUMPHUM KVBL KARIM KOSOVO KNSD KUIR KWHG KWBGXF KWMNU KPBT KKNP KERF KCRT KVIS KWRC KVIP KTFS KMARR KDGR KPAI KDE KTCRE KMPIO KUNRAORC KHOURY KAWS KPAK KOEM KCGC KID KVRP KCPS KIVR KBDS KWOMN KIIC KTFNJA KARZAI KMVP KHJUS KPKOUNSC KMAR KIBL KUNA KSA KIS KJUSAF KDEV KPMO KHIB KIRD KOUYATE KIPRZ KBEM KPAM KDET KPPD KOSCE KJUSKUNR KICCPUR KRMS KWMNPREL KWMJN KREISLER KWM KDHS KRV KPOV KWMNCI KMPL KFLD KWWN KCVM KIMMITT KCASC KOMO KNATO KDDG KHGH KRF KSCAECON KWMEN KRIC
PREL PINR PGOV PHUM PTER PE PREF PARM PBTS PINS PHSA PK PL PM PNAT PHAS PO PROP PGOVE PA PU POLITICAL PPTER POL PALESTINIAN PHUN PIN PAMQ PPA PSEC POLM PBIO PSOE PDEM PAK PF PKAO PGOVPRELMARRMOPS PMIL PV POLITICS PRELS POLICY PRELHA PIRN PINT PGOG PERSONS PRC PEACE PROCESS PRELPGOV PROV PFOV PKK PRE PT PIRF PSI PRL PRELAF PROG PARMP PERL PUNE PREFA PP PGOB PUM PROTECTION PARTIES PRIL PEL PAGE PS PGO PCUL PLUM PIF PGOVENRGCVISMASSEAIDOPRCEWWTBN PMUC PCOR PAS PB PKO PY PKST PTR PRM POUS PRELIZ PGIC PHUMS PAL PNUC PLO PMOPS PHM PGOVBL PBK PELOSI PTE PGOVAU PNR PINSO PRO PLAB PREM PNIR PSOCI PBS PD PHUML PERURENA PKPA PVOV PMAR PHUMCF PUHM PHUH PRELPGOVETTCIRAE PRT PROPERTY PEPFAR PREI POLUN PAR PINSF PREFL PH PREC PPD PING PQL PINSCE PGV PREO PRELUN POV PGOVPHUM PINRES PRES PGOC PINO POTUS PTERE PRELKPAO PRGOV PETR PGOVEAGRKMCAKNARBN PPKO PARLIAMENT PEPR PMIG PTBS PACE PETER PMDL PVIP PKPO POLMIL PTEL PJUS PHUMNI PRELKPAOIZ PGOVPREL POGV PEREZ POWELL PMASS PDOV PARN PG PPOL PGIV PAIGH PBOV PETROL PGPV PGOVL POSTS PSO PRELEU PRELECON PHUMPINS PGOVKCMABN PQM PRELSP PRGO PATTY PRELPGOVEAIDECONEINVBEXPSCULOIIPBTIO PGVO PROTESTS PRELPLS PKFK PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PARAGRAPH PRELGOV POG PTRD PTERM PBTSAG PHUMKPAL PRELPK PTERPGOV PAO PRIVATIZATION PSCE PPAO PGOVPRELPHUMPREFSMIGELABEAIDKCRMKWMN PARALYMPIC PRUM PKPRP PETERS PAHO PARMS PGREL PINV POINS PHUMPREL POREL PRELNL PHUMPGOV PGOVQL PLAN PRELL PARP PROVE PSOC PDD PRELNP PRELBR PKMN PGKV PUAS PRELTBIOBA PBTSEWWT PTERIS PGOVU PRELGG PHUMPRELPGOV PFOR PEPGOV PRELUNSC PRAM PICES PTERIZ PREK PRELEAGR PRELEUN PHUME PHU PHUMKCRS PRESL PRTER PGOF PARK PGOVSOCI PTERPREL PGOVEAID PGOVPHUMKPAO PINSKISL PREZ PGOVAF PARMEUN PECON PINL POGOV PGOVLO PIERRE PRELPHUM PGOVPZ PGOVKCRM PBST PKPAO PHUMHUPPS PGOVPOL PASS PPGOV PROGV PAGR PHALANAGE PARTY PRELID PGOVID PHUMR PHSAQ PINRAMGT PSA PRELM PRELMU PIA PINRPE PBTSRU PARMIR PEDRO PNUK PVPR PINOCHET PAARM PRFE PRELEIN PINF PCI PSEPC PGOVSU PRLE PDIP PHEM PRELB PORG PGGOC POLG POPDC PGOVPM PWMN PDRG PHUMK PINB PRELAL PRER PFIN PNRG PRED POLI PHUMBO PHYTRP PROLIFERATION PHARM PUOS PRHUM PUNR PENA PGOVREL PETRAEUS PGOVKDEM PGOVENRG PHUS PRESIDENT PTERKU PRELKSUMXABN PGOVSI PHUMQHA PKISL PIR PGOVZI PHUMIZNL PKNP PRELEVU PMIN PHIM PHUMBA PUBLIC PHAM PRELKPKO PMR PARTM PPREL PN PROL PDA PGOVECON PKBL PKEAID PERM PRELEZ PRELC PER PHJM PGOVPRELPINRBN PRFL PLN PWBG PNG PHUMA PGOR PHUMPTER POLINT PPEF PKPAL PNNL PMARR PAC PTIA PKDEM PAUL PREG PTERR PTERPRELPARMPGOVPBTSETTCEAIRELTNTC PRELJA POLS PI PNS PAREL PENV PTEROREP PGOVM PINER PBGT PHSAUNSC PTERDJ PRELEAID PARMIN PKIR PLEC PCRM PNET PARR PRELETRD PRELBN PINRTH PREJ PEACEKEEPINGFORCES PEMEX PRELZ PFLP PBPTS PTGOV PREVAL PRELSW PAUM PRF PHUMKDEM PATRICK PGOVKMCAPHUMBN PRELA PNUM PGGV PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PIND PTEP PTERKS PGOVJM PGOT PRELMARR PGOVCU PREV PREFF PRWL PET PROB PRELPHUMP PHUMAF PVTS PRELAFDB PSNR PGOVECONPRELBU PGOVZL PREP PHUMPRELBN PHSAPREL PARCA PGREV PGOVDO PGON PCON PODC PRELOV PHSAK PSHA PGOVGM PRELP POSCE PGOVPTER PHUMRU PINRHU PARMR PGOVTI PPEL PMAT PAN PANAM PGOVBO PRELHRC

Browse by classification

Community resources

courage is contagious

Viewing cable 04ABUDHABI1824, UAEG ADDRESSES COMPLAINTS OF U.S. PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04ABUDHABI1824.
Reference ID Created Released Classification Origin
04ABUDHABI1824 2004-06-02 11:49 2011-08-30 01:44 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Abu Dhabi
null
Diana T Fritz  02/06/2007 05:52:03 PM  From  DB/Inbox:  Search Results

Cable 
Text:                                                                      
                                                                           
      
UNCLASSIFIED

SIPDIS
TELEGRAM                                            June 02, 2004


To:       No Action Addressee                                    

Action:   Unknown                                                

From:     AMEMBASSY ABU DHABI (ABU DHABI 1824 - ROUTINE)         

TAGS:     ECON, ETRD, KIPR                                       

Captions: None                                                   

Subject:  UAEG ADDRESSES COMPLAINTS OF U.S. PHARMACEUTICAL       
          COMPANIES                                              

Ref:      None                                                   
_________________________________________________________________
UNCLAS        ABU DHABI 01824

SIPDIS
CXABU:
    ACTION: ECON 
    INFO:   P/M AMB DCM POL 
Laser1:
    INFO:   FCS 

DISSEMINATION: ECON
CHARGE: PROG

APPROVED: AMB: MWAHBA
DRAFTED: ECON: CCRUMPLER
CLEARED: ADCM: HOLSINWINDECKER; ECON: OJOHN; CGD: MCARVER

VZCZCADI745
RR RUEHC RUEHGV RUCNWTO RUCPDOC RUEHRH RUEHDE
DE RUEHAD #1824/01 1541149
ZNR UUUUU ZZH
R 021149Z JUN 04
FM AMEMBASSY ABU DHABI
TO RUEHC/SECSTATE WASHDC 4609
INFO RUEHGV/USMISSION GENEVA 0550
RUCNWTO/WORLD TRADE ORGANIZATION COLLECTIVE
RUCPDOC/USDOC WASHDC
RUEHRH/AMEMBASSY RIYADH 1360
RUEHDE/AMCONSUL DUBAI 4047
UNCLAS SECTION 01 OF 02 ABU DHABI 001824 
 
SIPDIS 
 
SENSITIVE 
 
DEPT FOR NEA, NEA/ARP, EB/TPP/MTA/IPC 
STATE PASS USTR - DBELL AND JBUNTIN 
USDOC FOR USPTO 
USDOC FOR 4250/DOC/MAC/ONE/GUGLIELMI 
GENEVA PASS USTR 
 
E.O. 12958: N/A 
TAGS: ECON ETRD KIPR WTO USTR TC
SUBJECT: UAEG ADDRESSES COMPLAINTS OF U.S. PHARMACEUTICAL 
COMPANIES 
 
REF: A) 02 ABU DHABI 4287 AND PREVIOUS 
     B) DUBAI 2044 AND PREVIOUS 
 
1.  (SBU) SUMMARY: SEEKING TO CAPITALIZE ON THE MOMENTUM OF 
THE U.S.-UAE TIFA COUNCIL MEETING IN APRIL, ECONOFF AND U.S. 
PHARMACEUTICAL MANUFACTURES MET WITH KEY UAEG OFFICIALS 
RECENTLY TO DISCUSS SEVERAL INCIDENCES OF PATENT 
INFRINGEMENT BY UAE HEALTH AUTHORITIES AND LOCAL COMPANIES. 
PRIOR TO THE TIFA COUNCIL MEETING, THE AMBASSADOR ALSO SENT 
LETTERS TO THE MOF, MOH AND SENIOR SHAYKHS OUTLINING THE 
PROBLEMS OF U.S. PHARMACEUTICAL COMPANIES HERE AND ADVISING 
THAT IPR ISSUES WOULD PLAY PROMINENTLY IN ANY FUTURE TRADE 
NEGOTIATIONS WITH THE UNITED STATES.  UAE MINISTER OF STATE 
FOR FINANCE DR. MOHAMMED KHALFAN BIN KHIRBASH AND HIS STAFF 
UNDERTOOK TO RESOLVE THE DISPUTES IMMEDIATELY AND CONVENED A 
MEETING WITH THE MOH TO ESTABLISH A WORKING GROUP ON 
PHARMACEUTICAL PATENTS.  THE MOF-MOH AGREED TO SETTLE THE 
DISPUTES IN FAVOR OF THE U.S. PATENT HOLDERS AND IN SPITE OF 
PROTESTS FROM LOCAL DRUG MANUFACTURER, JULPHAR -- A WELL- 
CONNECTED COMPANY WITH TIES TO THE RAS AL KHAYMAH RULING 
FAMILY.  END SUMMARY. 
 
----------------------------------------- 
U.S. COMPANIES ALLEGE PATENT INFRINGEMENT 
----------------------------------------- 
 
2.  (SBU) ACCOMPANIED BY ECONOFF, PFIZER'S REGIONAL 
REPRESENTATIVE AND MSD'S MIDDLE EAST DIRECTOR MET SEPARATELY 
WITH UAE MINISTRY OF FINANCE (MOF) ASSISTANT UNDERSECRETARY 
KHALID AL-BUSTANI AND UAE MINISTRY OF HEALTH (MOH) DIRECTOR 
OF DRUG CONTROL DR. EASA AL-MANSOURI ON MAY 15 AND MAY 18, 
RESPECTIVELY.  THE U.S. EXECS WANTED TO FOLLOW-UP ON A 
NUMBER OF PATENT ISSUES DISCUSSED DURING THE U.S.-UAE TIFA 
COUNCIL MEETING IN WASHINGTON IN APRIL, INCLUDING: 
 
-- THE REGISTRATION BY THE MOH OF THE VIAGRA COMPOSITE, 4M6. 
THE REGISTRATION IS A VIOLATION OF PFIZER'S VIAGRA PATENT 
VALID IN THE UNITED STATES UNTIL 2006 AND A VIOLATION OF THE 
2002 MOU WITH PHRMA (REF A) STATING THAT THE UAE WOULD 
ACCEPT THE UNITED STATES AS THE COUNTRY OF ORIGIN FOR THIS 
AND OTHER NAMED DRUGS; 
 
-- THE REGISTRATION BY THE MOH OF A DRUG CALLED SATIBO, 
WHICH ALSO CONTAINS VIAGRA AND VIOLATES PFIZER'S DATA 
EXCLUSIVITY IN THE UAE AS WELL AS THE UAE ANTIFRAUD AND 
ANTICHEATING LAW NO. 4 OF 1979; 
 
-- THE PURCHASE BY THE DUBAI DEPARTMENT OF HEALTH AND 
MEDICAL SERVICES (DOHMS) OF A GENERIC VERSION OF MSD'S 
ZOCOR.  ONLY THE U.S. PATENTED VERSION OF ZOCOR IS 
REGISTERED IN THE UAE; THE VARIOUS HEALTH AUTHORITIES HERE 
MUST PURCHASE DRUGS REGISTERED BY THE MOH; 
 
-- THE NEED FOR FEDERAL LEGISLATION IN THE UAE CODIFYING THE 
TERMS OF THE 2002 MOU AND MINISTRY OF HEALTH DECREE 404 
PROTECTING PHARMACEUTICAL PATENTS AND DATA EXCLUSIVITY IN 
THE UAE. 
 
3.  (SBU) IT BECAME CLEAR DURING THE MEETINGS THAT THE CAUSE 
OF CONFUSION WAS TWO-FOLD: (1) LOCAL COMPANY JULPHAR HAD 
INAPPROPRIATELY USED A U.S. PATENT IMPROVEMENT TO OBTAIN 
MARKETING APPROVAL IN THE UAE FOR THE VIAGRA COMPOSITE 4M6; 
THE MOH WAS UNAWARE THAT A U.S. PATENT DOES NOT/NOT GRANT A 
COMPANY MARKETING RIGHTS IN THE UNITED STATES (OR IN A THIRD 
COUNTRY), AND (2) MOH WORKING-LEVEL OFFICIALS AND THE 
VARIOUS HEALTH AUTHORITIES WERE NOT FAMILIAR WITH THE TERMS 
(SPECIFICALLY, THE COUNTRY OF ORIGIN COMMITMENTS) OF THE 
2002 MOU.  (NOTE: ALMOST EVERY EMIRATE IN THE UAE MAINTAINS 
ITS OWN HEALTH AUTHORITY, WHICH COORDINATES THE PURCHASE AND 
DISTRIBUTION OF DRUGS AMONG THE NETWORK OF GOVERNMENT-RUN 
CLINICS AND HOSPITALS WITHIN ITS JURISDICTION.  END NOTE.) 
 
4.  (SBU) DR. EASA'S ADVISER INITIALLY ARGUED THAT THE 2002 
MOU WAS UNFAIR TO EUROPEAN AND FOREIGN DRUG MANUFACTURERS 
AND WAS NO LONGER NECESSARY GIVEN THE UAE'S NEW PATENT 
LEGISLATION.  ECONOFF REMINDED THE UAEG OFFICIALS THAT THE 
2002 MOU SOUGHT TO ADDRESS SPECIFIC CONCERNS RAISED BY THE 
USG AND PHARMACEUTICAL MANUFACTURES FOR PROTECTION OF U.S. 
INTELLECTUAL PROPERTY.  FURTHERMORE, THE 2002 MOU WOULD 
REMAIN IN EFFECT UNTIL THE UAEG AND PHRMA SOUGHT TO ANNUL 
THE AGREEMENT, AND UNTIL SUCH TIME, THE VARIOUS HEALTH 
AUTHORITIES IN THE UAE WOULD BE REQUIRED TO ABIDE BY THOSE 
COMMITMENTS.  DR. EASA ACQUIESCED, BUT SAID THAT HE WOULD BE 
UNABLE TO DEREGISTER ANY OF LOCAL MANUFACTURER JULPHAR'S 
PRODUCTS "FOR POLITICAL REASONS." 
 
------------------------------------------ 
MOF TAKES THE LEAD TO RESOLVE THE DISPUTES 
------------------------------------------ 
 
5.  (SBU) AL-BUSTANI SUBSEQUENTLY CONVENED A SERIES OF 
MEETINGS MAY 25-27 WITH MOF PATENT DIRECTOR JAMAL NASSER 
LOOTAH AND DR. EASA TO DISCUSS THE ISSUES OF U.S. 
PHARMACEUTICAL COMPANIES IN DETAIL.  WE UNDERSTAND THAT AL- 
BUSTANI REMINDED HIS COLLEAGUES THAT DR. KHIRBASH HAD 
PLEDGED HIS PERSONAL ATTENTION AT THE TIFA COUNCIL MEETING 
TO RESOLVE THE PHARMACEUTICAL PATENT ISSUES WITH U.S. 
COMPANIES IMMEDIATELY.  (COMMENT: AL-BUSTANI PROBABLY ALSO 
INFORMED HIS COLLEAGUES THAT IPR ISSUES WOULD HINDER THE 
UAE'S EFFORTS TO CONCLUDE LONGER-TERM AN FTA WITH THE UNITED 
STATES.  END COMMENT.) 
 
6.  (SBU) LOOTAH CONTACTED ECONOFF ON MAY 29 AND -- SPEAKING 
ON BEHALF OF DR. KHIRBASH -- CONFIRMED THAT MOF AND MOH ARE 
"TOTALLY" COMMITTED TO THE 2002 MOU.  LOOTAH FURTHER STATED 
THAT THE MOF HAD GIVEN THE MOH A GRACE PERIOD OF ONE WEEK 
(UPON REQUEST OF THE MOH) TO SETTLE THE MATTERS WITH PHRMA, 
OTHERWISE THE MOF UNILATERALLY WOULD CANCEL ALL MARKETING 
APPROVALS THAT U.S. COMPANIES CLAIM INFRINGE UPON THEIR 
PHARMACEUTICAL PATENTS. 
 
7.  (SBU) LOOTAH ALSO EXPLAINED THAT THE MOH WOULD MEET WITH 
THE GENERAL DIRECTOR OF EVERY HEALTH AUTHORITY IN THE UAE TO 
PUT AN END TO THE PURCHASE OF UNREGISTERED DRUGS BY HEALTH 
AUTHORITIES THROUGH AN UNAUTHORIZED SUPPLIER OR GENERIC 
MANUFACTURER.  IN A SEPARATE CONVERSATION, AL-BUSTANI TOLD 
ECONCHIEF THAT HE EXPECTED THE MOH ALSO TO INSTRUCT THE 
VARIOUS HEALTH AUTHORITIES ABOUT THE DETAILS OF THE UAEG'S 
COMMITMENTS UNDER THE 2002 MOU. 
 
8.  (SBU) MOF AND MOH ALSO MET WITH JULPHAR'S 
REPRESENTATIVES MAY 31 TO EXPLAIN THE RIGHTS AND LIMITATIONS 
OF ITS U.S. PATENT FOR 4M6.  BACKED BY INFORMATION FROM 
USPTO, MOH SAID IT WOULD DEREGISTER 4M6 IN THE UAE BECAUSE 
THE U.S. PATENT DID NOT ALLOW THE COMPANY TO MARKET THE DRUG 
IN THE UNITED STATES.  MOH, THEREFORE, WOULD NOT ALLOW 
JULPHAR TO MARKET THE SAME DRUG IN THE UAE.  MOH ALSO 
UNDERTOOK TO ISSUE A LETTER TO ITS COUNTERPART AGENCIES IN 
THE GCC INFORMING OF THE DEREGISTRATION OF 4M6. 
 
------- 
COMMENT 
------- 
 
9.  (SBU) WE ARE OPTIMISTIC THAT THE MOH WILL PULL 4M6 AND 
SATIBO FROM THE SHELVES OF UAE PHARMACIES IMMINENTLY, AND 
WILL MAKE GOOD ON ITS PROMISES TO BETTER INFORM THE VARIOUS 
HEALTH AUTHORITIES OF THE UAE'S COMMITMENTS TO U.S. 
PHARMACEUTICAL PATENT HOLDERS UNDER THE 2002 MOU.  NO DOUBT 
THE RECENT TIFA COUNCIL MEETING AND THE PROSPECT OF FTA 
NEGOTIATIONS WITH THE UNITED STATES PROVIDED MOMENTUM WITHIN 
THE UAEG TO RESOLVE THESE LONG-STANDING PHARMACEUTICAL 
PATENT ISSUES AS QUICKLY AS POSSIBLE.  THIS INCIDENT 
HIGHLIGHTS THE NEED, HOWEVER, FOR FEDERAL LEGISLATION 
CODIFYING THE TERMS OF THE 2002 MOU (ISSUES OF COUNTRY OF 
ORIGIN, DATA EXCLUSIVITY AND MARKETING RIGHTS) TO AVOID SUCH 
MISUNDERSTANDINGS IN THE FUTURE. 
 
10.  (U) THIS CABLE WAS COORDINATED WITH DUBAI. 
 
WAHBA